Graphene Brain Chip Pioneers Cancer Cell Localization

Updated on: November 07,2024

Graphene Brain Chip Pioneers Cancer Cell Localization

Updated on:November 07,2024

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on: March 22,2024

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on:March 22,2024

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Updated on: December 23,2023

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Updated on:December 23,2023

Lung cancer screening dramatically increases long-term survival rate

byRadiological Society of North AmericaAxial CT images of pulmonary nodules. (A) Malignant nodule. (B) Benign nodule. Credit: Radiological Society of North AmericaDiagnosing early-stage lung can

Updated on: December 22,2023

Lung cancer screening dramatically increases long-term survival rate

byRadiological Society of North AmericaAxial CT images of pulmonary nodules. (A) Malignant nodule. (B) Benign nodule. Credit: Radiological Society of North AmericaDiagnosing early-stage lung can

Updated on:December 22,2023

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on: December 22,2023

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on:December 22,2023

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on: January 11,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on:January 11,2024

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on: December 22,2023

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on:December 22,2023

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on: June 11,2024

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on:June 11,2024

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on: December 20,2023

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on:December 20,2023

Liver cancer: How liver cells go astray

byUniversity of BaselOne of the main causes of liver cancer is excessive alcohol consumption. Credit: Biozentrum, University of BaselThe causes of liver cancer are manifold. In addition to metab

Updated on: December 22,2023

Liver cancer: How liver cells go astray

byUniversity of BaselOne of the main causes of liver cancer is excessive alcohol consumption. Credit: Biozentrum, University of BaselThe causes of liver cancer are manifold. In addition to metab

Updated on:December 22,2023

Chemotherapy drug temozolomide analog shows promise in treating glioma

by Bob Yirka , Medical XpressCredit: Unsplash/CC0 Public DomainA team of researchers from Yale University and Yale School of Medicine has developed a temozolomide analog for use as a chemotherapy drug

Updated on: December 22,2023

Chemotherapy drug temozolomide analog shows promise in treating glioma

by Bob Yirka , Medical XpressCredit: Unsplash/CC0 Public DomainA team of researchers from Yale University and Yale School of Medicine has developed a temozolomide analog for use as a chemotherapy drug

Updated on:December 22,2023

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024